Clinical Trials on new therapies for MS based at the National Hospital for Neurology and Neurosurgery (NHNN) and the Leonard Wolfson Experimental Neurology Centre (LWENC) in Queen Square:
- Octopus: a new trial for progressive MS
- MS-STAT2
- Alexander Disease Trial
- NMR Research Unit Trials Office
New Clinical Trials that are based in other London Hospitals, with MRI carried out in the Queen Square Multiple Sclerosis Centre:
AttackMS: A new Clinical Trial that is based in other London Hospitals, with MRI carried out in the Queen Square Multiple Sclerosis Centre. This trial is on Natalizumab for treatment of inflammatory demyelination suggestive of MS, or definite MS, at first presentation.
- Video: AttackMS: assessing the feasibility of multiple sclerosis treatment within 14 days of presentation.
- Video: Why has the AttackMS trial been suggested to me? Some patients explain more.
ChariotMS: This is a new multi-centre (20 sites across the U.K) trial of cladribine in patients with advanced MS.
CLOSED TRIAL: MS-SMART: MS-Secondary Progressive Multi-Arm Randomisation Trial.
As a University, UCL uses personally-identifiable information to conduct research to improve health, care and services. As a publicly-funded organisation, we have to ensure that it is in the public interest when we use personally-identifiable information from people who have agreed to take part in research. This means that when you agree to take part in a research study, we will use your data in the ways needed to conduct and analyse the research study. Your rights to access, change or move your information are limited, as we need to manage your information in specific ways in order for the research to be reliable and accurate. If you withdraw from the study, we will keep the information about you that we have already obtained. To safeguard your rights, we will use the minimum personally-identifiable information possible.
Health and care research should serve the public interest, which means that we have to demonstrate that our research serves the interests of society as a whole. We do this by following the UK Policy Framework for Health and Social Care Research.
If you wish to raise a complaint on how we have handled your personal data, you can contact our Data Protection Officer who will investigate the matter. If you are not satisfied with our response or believe we are processing your personal data in a way that is not lawful you can complain to the Information Commissioner's Office (ICO).
UCL Data Protection Officer can be contacted on data-protection@ucl.ac.uk